Page 153 - Read Online
P. 153

Nardulli. Plast Aesthet Res 2020;7:15  I  http://dx.doi.org/10.20517/2347-9264.2019.56                                                  Page 3 of 10


                        A                                   B




























               Figure 1. A: A patient who developed left upper limb lymphedema during neoadjuvant therapy with Paclitaxel for breast cancer; B: After
               undergoing left nipple sparing mastectomy, sentinel lymph node biopsy and immediate breast reconstruction with a prepectoral implant,
               the lymphedema improved spontaneously, especially at the level of the forearm

               Table 1. Staging system for lymphedema

               Stage 0 (or Ia)  which refers to a latent or sub-clinical condition where swelling is not yet evident despite impaired lymph transport, subtle
                           changes in tissue fluid/composition, and changes in subjective symptoms. It may exist months or years before overt edema
                           occurs (Stages I-III)
               Stage I     represents an early accumulation of fluid relatively high in protein content (e.g., in comparison with “venous” edema) which
                           subsides with limb elevation. Pitting may occur. An increase in various proliferating cells may also be seen
               Stage II    signifies that limb elevation alone rarely reduces tissue swelling and pitting is manifest. Late in Stage II, the limb may not pit as
                           excess subcutaneous fat and fibrosis supervenes
               Stage III   encompasses lymphostatic elephantiasis where pitting can be absent and trophic skin changes such as acanthosis, alterations
                           in skin character and thickness, further deposition of fat and fibrosis, and warty overgrowths have developed
                                                                  [17]
               This table summarizes the lymphedema staging system according to ISL , from the 2016 Consensus Document of the ISL [17]
               (adapted). These Stages only refer to the physical condition of the extremities. ISL: International Society of Lymphology

               The first-line treatment for BCRL is a set of nonsurgical and conservative measures known as Complex
               Decongestive Therapy (CDT). CDT includes lymphatic manual drainage, bandaging, skin care, exercise,
               patient education and is coupled with the use of compression garments. The aim of CDT is to reduce
               limb volume first, followed by maintenance of the results achieved. Normally, patients suffering from
               lymphedema require lifelong adherence to such therapeutic measures [1,19,20] . Consequently, non-compliance
               to conservative therapy is frequent. Nevertheless, in recent years, interest in lymphedema surgery has
               increased all over the world and there have been many advances in both surgical techniques and imaging
               modalities. Therefore, surgery can be offered as a complementary or alternative therapeutic strategy for
               lymphedema, when conservative measures are inadequate [2,21] .

               Below, we present an overview of the main surgical techniques currently adopted for the treatment of
               BCRL.


               SURGICAL TREATMENT FOR BCRL
               Surgical techniques for BCRL can be classified as physiological or reconstructive, and ablative or debulking
               procedures [2,20] . Physiological or reconstructive techniques aim to restore lymphatic pathways in the axilla
   148   149   150   151   152   153   154   155   156   157   158